antitrust

IN RE: COPAXONE ANTITRUST LITIGATION

22-cv-01232
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

In re: Copaxone Antitrust Litigation, docket 22-cv-01232, targets Teva Pharmaceuticals' conduct around Copaxone, a blockbuster multiple sclerosis drug. Antitrust cases of this type typically allege that a brand-name manufacturer used patent settlements, citizen petitions, or other tactics to delay generic entry and maintain supracompetitive prices. Copaxone has been the subject of prior antitrust scrutiny nationally. Plaintiffs in cases like this are commonly direct or indirect purchasers — insurers, pharmacy benefit managers, or end consumers — seeking damages for overcharges during the period generic competition was allegedly suppressed. No court has been confirmed in the record.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

  • • Alleged anticompetitive delay of generic Copaxone entry
  • • Patent settlement or citizen petition abuse
  • • Damages period and class certification
  • • Direct versus indirect purchaser standing
  • • Teva's market conduct and pricing practices
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
Advertisement

Case Timeline

1 event
info
Other April 20, 2026

2:22-cv-01232 IN RE: COPAXONE ANTITRUST LITIGATION

A new antitrust case was filed against the makers of Copaxone, a multiple sclerosis drug, in what appears to be a consolidated multidistrict proceeding. Antitrust suits targeting branded pharmaceutical companies typically allege that the manufacturer blocked or delayed generic competition — costing buyers, insurers, or patients inflated prices for years. The docket number 2:22-cv-01232 places this in 2022 federal court filing.

description View filing open_in_new
Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

2 hours, 4 minutes ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.